A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 5,111 shares of ZTS stock, worth $903,318. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,111
Previous 5,011 2.0%
Holding current value
$903,318
Previous $869 Million 14.95%
% of portfolio
0.08%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $17,258 - $19,648
100 Added 2.0%
5,111 $999 Million
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $145 - $178
-1 Reduced 0.02%
5,011 $869 Million
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $203,442 - $245,526
1,228 Added 32.45%
5,012 $848 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $573,048 - $757,140
3,784 New
3,784 $747 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.